Products
-
- BBB DamageCategories
- Neurotransmitter Antibodies & Receptor Antibodies
- Ionotropic Receptor AntibodiesMetabotropic Receptor AntibodiesNeurotransmitter AntibodiesTransporter AntibodiesSignal Channel Antibodies
- Calcium Channel AntibodiesChloride Channel AntibodiesDense-Core Vesicles AntibodiesNitric Oxide Channel AntibodiesStroke Pathology Antibodies
- Neurogenesis AntibodiesNeuronal Growth & Development AntibodiesNeuronal Growth & Development AntibodiesNeuronal Metabolism AntibodiesSignal Transduction AntibodiesStroke-Related Cell Markers Antibodies
- Glial Cell Marker AntibodiesNeural Stem Cell Marker AntibodiesNeuron Marker AntibodiesSynaptic Marker AntibodiesCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Fluorescent adenosine agonist [NECA] (AC119)
Cat.#: ASSD-119
Specifications
Description A fluorescent adenosine receptor ligand derived from NECA, non-selective adenosine agonist. Fluorescent adenosine receptor agonist (pEC50 values are 8.57, 8.47, 6.76 and 5.69 for A3, A1, A2A and A2B respectively). Synonyms Fluorescent Adenosine receptor Agonist (A-633-AG), A-633-AG, ABEA-X-BY630 Size 500 μg Applications For ligand binding; fluorescence imaging; high content analysis; kinetic analysis; cell sorting at adenosine A1 / A2A / A3 receptors use solutions up to 100 nM. Molecule Weight 925 Purity >97% Solubility Soluble in DMSO Form Purple solid Excitation 638 nm Emission 657 nm Storage Store at -20° C (protect from light) Shipping Shipped at 4°C Important We recommend briefly sonicating the sample when using to ensure it is fully dissolved and the solution is homogeneous. However, we do not recommend using the product after subjecting it to repetitive freeze-thaw cycles. Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-126 Fluorescent H2 antagonist [aminopotentidine] (AC126) 50 μg inquiry ASSD-118 BrdU (5-Bromo-2′-deoxyuridine) (AC118) 200 mg, 100 mg, 1 g, 5g inquiry ASSD-112 Propidium Iodide Staining Solution (1mg/ml) in water (AC112) 1 mL inquiry ASSD-176 Rhodamine B isothiocyanate (AC176) 100 mg, 500 mg inquiry ASSD-170 BAPTA-AM (AC170) 25 mg inquiry ASSD-178 5-(Iodoacetamido)fluorescein (AC178) 25 mg, 100 mg, 250 mg inquiry ASSD-174 Coomassie Blue R-250 (AC174) 25 g, 100 g inquiry ASSD-140 A2B covalent ligand (AC140) 50 μg inquiry ASSD-209 Tetramethylrhodamine isothiocyanate Isomer R (AC209) 5 mg, 10 mg inquiry ASSD-219 Tetramethylrhodamine-6-maleimide (AC219) 5 mg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
We are committed to accelerating progress in stroke research and drug development.
Copyright © Ace Therapeutics. All rights reserved.0Inquiry Basket